GPC3 and liver cancer: Since GPC3 was revealed as a new marker of liver cancer in 1997, its biological function and expression pattern have been gradually identified, and it has evolved from a potential tumor marker to an important indicator for clinical detection, and a series of GPC3 target therapies has been developed.